Treatment with these two compounds resulted in the most significant downregulatory transcriptomic changes in cancer-related genes involved in e.g., vasculogenesis, TGF-β signaling, or positive regulation of proliferation, among others. This evidence concerns the gene TGFB1 and cancer.